These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Persistence of babesiosis for >2 years in a patient on rituximab for rheumatoid arthritis.
    Author: Raffalli J, Wormser GP.
    Journal: Diagn Microbiol Infect Dis; 2016 Jun; 85(2):231-2. PubMed ID: 27036977.
    Abstract:
    We report a patient who was being treated with rituximab for rheumatoid arthritis who developed Babesia microti infection that persisted for 26 months despite prolonged anti-babesia drug therapy. The explanation for the persistence was likely to have been the long-term immunocompromising effects of rituximab, as evidenced by seronegativity for B. microti antibodies that lasted for more than 1 year after onset of infection.
    [Abstract] [Full Text] [Related] [New Search]